Stability Study of a Compounded Sublingual Buprenorphine Solution for Neonatal Opioid Withdrawal Syndrome.  Ahmadi A, Cutaia DR, Perkins JR, Zhao F, Gawronski KM, Austin DL.  J Pediatr Pharmacol Ther. 2023;28(8):710-713. doi: 10.5863/1...

Is Eat, Sleep, Console the New Standard of Care?  Rodriguez RJ, Schwartz ADC, Ruiz MME.  J Pediatr Pharmacol Ther. 2023;28(6):573-575. doi: 10.5863/1551-6776-28.6.573. Epub 2023 Oct 28. PMID: 38130342; PMCID: PMC10731940. https://www....

Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.  Mascarenhas M, Wachman EM, Chandra I, Xue R, Sarathy L, Schiff DM.  Pediatrics. 2024 Jan 5:e2023062871. doi: 10.1542/peds.2023-0628...

Transfer Timing and the Length of Medication Weaning for Neonatal Opioid Withdrawal Syndrome.  Botticello AL, Chen YL, Smith MG, Chung AF, Marchetta CM, McMahon M, Van Orden K, Sulter A, Weinstein L, Zalewitz J, O'Neill J.  Hosp Pediat...

Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use.  Dumbhare O, Taksande A.  Cureus. 2023 Oct 30;15(10):e47980. doi: 10.7759/cureus.47980. PMID: 38034154; PMCID: PMC10686242. https://www.ncbi.nlm.nih.gov/p...

Gabapentin as Adjunctive Therapy in Neonatal Opioid Withdrawal Syndrome: A Case Series.  Patz C, Liviskie C, Bird M, Zeller B, Vesoulis ZA, Smyser CD, McPherson C.  J Pediatr Pharmacol Ther. 2023;28(4):368-373. doi: 10.5863/1551-6776-28....